# QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers

> **NCT04050709** · PHASE1 · COMPLETED · sponsor: **ImmunityBio, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Locally Advanced Solid Tumor
- Metastatic Cancer
- Solid Tumor

## Interventions

- **BIOLOGICAL:** PD-L1 t-haNK

## Key facts

- **NCT ID:** NCT04050709
- **Lead sponsor:** ImmunityBio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2021-03-30
- **Final completion:** 2026-03-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050709, "QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04050709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*